CLINICAL_TRIALS trial_result · 2021-12-22

Clinical Trial Update: A Six Week Efficacy, Safety and Tolerability Study of V565 in Crohn's Disease [Phase 2]

A Phase 2 trial evaluating efficacy, safety, and tolerability of V565 in Crohn's disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: VHsquared Ltd. | Conditions: Crohn's Disease | Phase 2 | Status: COMPLETED | Results posted: 2021-12-22